March 27, 2017 9:42 PM ET

Biotechnology

Company Overview of CardioVascular BioTherapeutics, Inc.

Key Executives for CardioVascular BioTherapeutics, Inc.

NameBoard RelationshipsTitleAge
Daniel C. Montano No RelationshipsCo-Founder and Chief Executive Officer67
Mickael A. Flaa CPA4 RelationshipsPresident, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director63
Grant Gordon 8 RelationshipsCo-Founder and Vice Chairman55
John W. Jacobs Ph.D.No RelationshipsChief Operating Officer, Chief Scientific Officer and Vice President66
Nabil Dib M.D., M.Sc., F.A.C.C.9 RelationshipsPrincipal Investigator for Phase II Heart Trial--
View More Key Executives

CardioVascular BioTherapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Calvin A. Wallen III 4 RelationshipsCardioVascular BioTherapeutics, Inc.--
Grant Gordon 8 RelationshipsCardioVascular BioTherapeutics, Inc.55
Mickael A. Flaa CPA 4 RelationshipsCardioVascular BioTherapeutics, Inc.63
Jon Ross 4 RelationshipsCardioVascular BioTherapeutics, Inc.--
Robert Schleizer 4 RelationshipsCardioVascular BioTherapeutics, Inc.--
View All Board Members

CardioVascular BioTherapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$480.0K
480.0K
321.1K
Bonus
Not meaningful
Total Short Term Compensation$480.0K
480.0K
404.2K
Total Value of Options
2.9M
Compensation as of Fiscal Year
CardioVascular BioTherapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Mobidiag Ltd Opens New Office in United Kingdom; Appoints Stuart Cranmer as Managing Director
March 27, 2017 7:00 AM ET
Orgenesis Inc. Announces Resignation of Etti Hanochi from its Board of Directors
March 24, 2017 4:38 PM ET
Silicon Therapeutics Appoints Woody Sherman as Chief Scientific Officer
March 24, 2017 2:15 PM ET
Retrophin, Inc. Appoints John A. Orwin to Board of Directors
March 23, 2017 9:11 PM ET
Arbutus Biopharma Corporation Appoints Daniel Burgess to the Board of Directors and Audit Committee
March 23, 2017 8:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CardioVascular BioTherapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.